Betül Arica Yegin

TL;DR: Lipid nanoparticles demonstrated their potential as a promising pharmaceutical formulation of paclitaxel as an injectable carrier system and entrapped in an amorphous state in the lipid matrix.

TL;DR: HDR was found to be an excellent tool for the determination of size and average size distribution of lipid nanocapsules and was able to detect micelles as a byproduct of nanocapule preparation while in PCS the sample dilution turned micells undetectable.

TL;DR: Encouraging results obtained offer reasons for optimism regarding the future of 5-FU nanoparticles as a promising drug delivery system which could be further improved by including either enteric coating or encapsulating the nanoparticles onto microparticles to overcome unanticipated degradation.

TL;DR: Alginate formulations exhibit promising properties of a controlled release form for sulindac; meanwhile they provide a distinct tissue protection in the stomach and duodenum and microscopic analyses of the mucosal damage demonstrated a significant mucoprotective effect of all bead formulation compared to the free drug.

TL;DR: This was the first experiment in the literature to use a transforming growth factor beta3 (TGF-β3)/chitosan combination and it is intended to change the formulation and perform this study again with a different TGF- β3/chitOSan preparation.